Canada · Delayed Price · Currency is CAD Satellos Bioscience Statistics
Total Valuation
TSX:MSCL has a market cap or net worth of CAD 174.38 million. The enterprise value is 126.16 million.
| Market Cap | 174.38M |
| Enterprise Value | 126.16M |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:MSCL has 185.51 million shares outstanding. The number of shares has increased by 40.78% in one year.
| Current Share Class | 185.51M |
| Shares Outstanding | 185.51M |
| Shares Change (YoY) | +40.78% |
| Shares Change (QoQ) | -2.27% |
| Owned by Insiders (%) | 9.02% |
| Owned by Institutions (%) | 1.71% |
| Float | 156.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.68 |
| P/TBV Ratio | 3.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.20 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.27 |
Financial Position
The company has a current ratio of 10.70
| Current Ratio | 10.70 |
| Quick Ratio | 9.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -87.59% and return on invested capital (ROIC) is -61.07%.
| Return on Equity (ROE) | -87.59% |
| Return on Assets (ROA) | -54.25% |
| Return on Invested Capital (ROIC) | -61.07% |
| Return on Capital Employed (ROCE) | -70.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.88M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TSX:MSCL has paid 158,789 in taxes.
| Income Tax | 158,789 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.17% in the last 52 weeks. The beta is 0.71, so TSX:MSCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +15.17% |
| 50-Day Moving Average | 0.74 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 71.23 |
| Average Volume (20 Days) | 261,218 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -23.24M |
| Operating Income | -33.51M |
| Pretax Income | -29.88M |
| Net Income | -30.04M |
| EBITDA | -33.49M |
| EBIT | -33.51M |
| Earnings Per Share (EPS) | -0.19 |
Balance Sheet
The company has 48.21 million in cash and n/a in debt, with a net cash position of 48.21 million or 0.26 per share.
| Cash & Cash Equivalents | 48.21M |
| Total Debt | n/a |
| Net Cash | 48.21M |
| Net Cash Per Share | 0.26 |
| Equity (Book Value) | 47.36M |
| Book Value Per Share | 0.26 |
| Working Capital | 47.35M |
Cash Flow
In the last 12 months, operating cash flow was -29.57 million and capital expenditures -8,786, giving a free cash flow of -29.58 million.
| Operating Cash Flow | -29.57M |
| Capital Expenditures | -8,786 |
| Free Cash Flow | -29.58M |
| FCF Per Share | -0.16 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:MSCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.78% |
| Shareholder Yield | -40.78% |
| Earnings Yield | -17.23% |
| FCF Yield | -16.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |